Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Institute to fund new melanoma trials co-ordinator

17 June 2015

Melanoma Research Institute to fund new melanoma trials co-ordinator at Auckland City Hospital

The Melanoma Research Institute of New Zealand today announced it will provide funding for a melanoma trials co-ordinator at Auckland City Hospital.

Once appointed, the new co-ordinator will work alongside Dr Rosalie Fisher and Dr Mike McCrystal on the Auckland District Health Board’s Cancer and Blood Service team.

Both doctors are welcoming the news of an extra set of hands, as it will boost the hospital’s capacity to hold vital trials for melanoma research.

“This is a very important step in increasing the capacity to undertake clinical trials in patients with melanoma,” said Dr Fisher. “I hope it will ultimately result in better survival rates of the Kiwis who are battling this devastating disease.”

Currently only two clinical trials are open to recruitment in New Zealand, but the Melanoma Research Institute is working to ensure there are more options available. Melanoma Research Institute director Dr Edward Watson said the new role is part of this push for greater access.

“The Institute has been working to increase access to clinical trials for New Zealanders suffering from advanced melanoma skin cancer and this new position will be a significant step forwards in achieving this aim,” Dr Watson said.

“We are enormously grateful to Mrs Paddy Carter, who has made this new role possible through her generous donation, which she made in remembrance of her husband Ron.”

Dr Watson said research is essential in order to combat melanoma in New Zealand, which has the highest incidence rate of anywhere in the world.

“The new treatments available today are a result of people participating in clinical trials in the past, so research is crucial,” Dr Watson said. “Taking part in a clinical trial also gives patients, especially those with advanced cancer, a chance to access new therapies that wouldn’t otherwise be available.”

The new trial co-ordinator will start at Auckland City Hospital on 1 July.

-ends-

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Testing And Decontamination: New Standard On Meth Residue

Standards New Zealand has today released NZS 8510:2017 Testing and decontamination of methamphetamine-contaminated properties ... More>>

ALSO:

Mince, Etc: US Food Poisoning Lawyer At Conference

As New Zealand chefs, food experts, and MPI debate what constitutes a cooked beef burger, leading US food safety litigator Bill Marler, who made his name prosecuting the burger company responsible for a major E. coli outbreak, is keynote speaker at the Food Integrity Conference. More>>

ALSO:

Petya: New Ransomware Campaign Hits Worldwide

A new ransomware campaign known as Petya is affecting computer networks using Microsoft Windows. It was first seen affecting systems in the Ukraine, but is quickly spreading across other computer networks in Europe. More>>

ALSO:

Skodafone Goneski: Sky TV, Vodafone Drop $3.44 Billion Merger Plan

Sky Network Television and Vodafone New Zealand have terminated their merger agreement which aimed to create the country's largest telecommunications and media group, and have withdrawn an appeal against the Commerce Commission's rejection of the plan. More>>

Quake Insurance: Reforms To EQC Act Announced

· Increasing the monetary cap from $100,000 (plus GST) to $150,000 (plus GST) for EQC building cover.
· Clarifying EQC land cover is for natural disaster damage that directly affects the insured residence or access to it... More>>

ALSO: